The first cases of congenital adrenal hyperplasia III with variable clinical manifestations in female monozygotic twins are presented. Twin "A" revealed severe hypertrophy of the clitoris, labial fusion and a visible introitus. However, twin "B" manifested moderate clitoral hypertrophy, a visible introitus and no labial fusion. Neither infant had palpable gonads.
INTRODUCTION
Congenital adrenal hyperplasia is an autosomal recessive disorder caused by decreased activity of one of the enzymes required for the synthesis of cortisol (Gala et al., 1969) . In the vast majority of cases, the enzyme involved is 21-hydroxylase (P450C21) (McKusick, 1987) . This defect leads to a negative feed back mechanism, causing an increased secretion of adrenocorticotropic hormone (ACTH), which in turn, stimulates an increased production of adrenal and androgenic hormones (White et al., 1987a) .
The affected female fetus undergoes masculinization to varying degrees, depending on the severity of the enzyme deficiency. In severe cases, aldosterone production is affected, with subsequent increased urinary sodium loss, hyperkalemia, dehydration, shock and possible death (White et al., 1987b; New et al., 1981 ; Murtaza et al., 1980; Miller and Levine, 1987) .
In monozygotic twins with this disorder, one would expect the degree of mas-culinization to be similar. In this report, we are presenting the first reported cases of monozygotic twins exhibiting significantly variable clinical manifestations.
CASE REPORT
Twin girls were delivered vaginally to a healthy 23 year old black woman after an uneventful 40 week gestation. Their weights were 3,267 g (Twin A) and 3,100 g (Twin B). There were separate diamniotic, dichorionic, placentas. The parents were unrelated and there was no significant family history.
Physical examination of Twin A revealed severe clitoral hypertrophy, labial fusion, and a visible introitus. Twin B manifested moderate clitoral hypertrophy, a visible introitus, and no labial fusion (Fig. 1) . Neither infant had palpable gonads. Clinical and laboratory findings of both twins are shown in Table 1 . Both neonates were asymptomatic at birth, and routine hematologic and biochemical studies were normal. Serum 17-OH progesterone concentrations however, were elevated in both children (Table 1) . Serum adrenocorticotropin concentrations were not measured. A clinical diagnosis of congenital adrenal hyperplasia was made, and the infants were treated with physiologic doses of cortisone acetate. Investigations of Nood types and subtypes, were performed and were identical, in- dicating the monozygotic origin of the twins. C h r o m o s o m a l preparations for k a r y o t y p i n g were made from P H A -s t i m u l a t e d cultures of peripheral blood lymphocytes and various banding techniques were applied (Verma and Babu, 1989) . Cytogenetic findings for both twins were 46,XX. Heteromorphic markers were evaluated utilizing restriction endonucleases AluI, and were found to be identical, thus confirming monozygosity (Fig. 2) . Neither of the twins was found to be a salt loser. Vol. 34, No. 3, 1989 DISCUSSION Because of separate placentation and significant differences of virilization, it was our initial clinical impression that our patients were dizygotic twins. We were, however, able to demonstrate monozygosity using standard blood typing and a restriction endonuclease technique.
Differences in secretion of adrenocorticotropin and androgenic steroids, and/or end organ response during critical periods in gestation are possible explanations for the dissimilar degrees of virilization. It is, however, interesting to note that the postnatal serum concentration of 17-hydroxyprogesterone in the moderately affected twin was approximately twice that of the severely affected infant.
These cases suggest that non-genetic factors may play a role in the degree of virilization of female fetuses with 21 hydroxylase deficiency. Alternatively, the affected enzymes may not be absent or deficient but functioning poorly. It has been demonstrated that monozygotic twins with double placentation, while genetically identical, may have dissimilar phenotypic characteristics. Future investigations using advanced technology may unmask many details about the molecular basis of these steroidogenic syndrome which in turn may lead to a better application of therapy.
